Hydrogel mediated delivery of trophic factors for neural repair

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 1, Issue 1, 2009, Pages 128-139

  Katz, Joshua S ^a   Burdick, Jason A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; ENZYMATIC MECHANISMS; INJECTABLE MATERIALS; MATERIAL PROCESSING; NEURAL APPLICATIONS; PARKINSON'S DISEASE; SPINAL CORD INJURIES (SCI); THERAPEUTIC POTENTIALS;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; MOLECULES; NEURODEGENERATIVE DISEASES; REPAIR;

HYDROGELS;

DRUG CARRIER; NANOMATERIAL; NERVE GROWTH FACTOR;

ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG FORMULATION; HUMAN; HYDROGEL; METHODOLOGY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; REVIEW; SYNTHESIS; ULTRASTRUCTURE;

ANIMALS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; HYDROGELS; NANOSTRUCTURES; NERVE GROWTH FACTORS; NERVE REGENERATION; NEUROGENESIS;

EID: 72049132984     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.10     Document Type: Review

References (90)

1. Johnson EO, Zoubos AB, Soucacos PN: Regeneration and repair of peripheral nerves. Injury 2005, 36(suppl 4):S24-S29.
2. Ma W, Fitzgerald W, Liu QY, O'shaughnessy TJ, Maric D, et al.: CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp Neurol 2004, 190(2):276-288.
3. Weber RV, Mackinnon SE: Bridging the neural gap. Clin Plast Surg 2005, 32(4):605-616.
4. Gautier SE, Oudega M, Fragoso M, Chapon P, Plant GW, et al.: Poly(alpha-hydroxyacids) for application in the spinal cord: Resorbability and biocompatibility with adult rat Schwann cells and spinal cord. J BiomedMater Res 1998, 42:642-654.
5. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J: Cellular and molecular mechanisms of glial scarring and progressive cavitation: In Vivo and In Vitro analysis of inflammation-induced secondary injury after CNS Trauma. J Neurosci 1999, 19:8182-8198.
6. Blesch A, Lu P, Tuszynski MH: Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 2002, 57:833-838.
7. Arevalo JC, Wu SH: Neurotrophin signaling: many exciting surprises!. Cell Mol Life Sci 2006, 63(13):1523-1537.
8. Aguayo AJ, Clarke DB, Jelsma TN, Kittlerova P, Friedman HC, et al.: Effects of neurotrophins on the survival and regrowth of injured retinal neurons. Ciba Found Symp 1996, 196(:):135-144 discussion 144-138.
9. Barde YA: Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 1994, 390:45-56.
10. Casaccia-Bonnefil P, Kong H, Chao MV: Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ 1998, 5(5):357-364.
11. Saito A, Tominaga T, Chan PH: Neuroprotective role of neurotrophins: relationship between nerve growth factor and apoptotic cell survival pathway after cerebral ischemia. Curr Atheroscler Rep 2005, 7(4):268-273.
12. Tessarollo L: Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev 1998, 9(2):125-137.
13. Jean I, Lavialle C, Barthelaix-Pouplard A, Fressinaud C: Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res 2003, 972(1-2):110-118.
14. Rosenberg SS, Ng BK, Chan JR: The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol 2006, 16(4):288-294.
15. Zhou L, Baumgartner BJ, Hill-Felberg SJ, Mcgowen LR, Shine HD: Neurotrophin-3 expressed In Situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 2003, 23:1424-1431.
16. Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH: Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 2004, 24(28):6402-6409.
17. Zhou L, Shine HD: Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury. J Neurosci Res 2003, 74:221-226.
18. Harbaugh RE, Saunders RL, Reeder RF: Use of implantable pumps for central nervous-system drug infusions to treat neurological disease. Neurosurgery 1988, 23(6):693-698.
19. Nomura H, Tator CH, Shoichet MS: Bioengineered strategies for spinal cord repair. J Neurotrauma 2006, 23(3-4):496-507.
20. Whittlesey KJ, Shea LD: Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/ biomaterial interface. Exp Neurol 2004, 190(1):1-16.
21. Anseth KS, Burdick JA: New directions in photopolymerizable biomaterials. MRS Bull 2002, 27:130-138.
22. Khare AR, Peppas NA: Release behavior of bioactive agents from pH-sensitive hydrogels. J Biomater Sci Polym Ed 1993, 4(3): 275-289
23. Mcnair AM: Using hydrogel polymers for drug delivery. Med Device Technol 1996, 7(10):16-22.
24. Anderson DG,Burdick JA, Langer R: Materials science. Smart biomaterials. Science, 2004, 305(5692): 1923-1924
25. Krewson CE, Klarman ML, Saltzman WM: Distribution of nerve growth-factor following direct delivery to brain interstitium. Brain Res 1995, 680(1-2):196-206.
26. Sayer FT, Oudega M, Hagg T: Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord. Exp Neurol 2002, 175(1):282-296.
27. Lee KY, Mooney DJ: Hydrogels for tissue engineering. Chem Eng Prog 2001, 101(7):1869-1879.
28. Carrodeguas RG, Lasa BV, Del Barrio JS: Injectable acrylic bone cements for vertebroplasty with improved properties. J BiomedMater Res B Appl Biomater 2004, 68(1):94-104.
29. Lewis G: Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review. J Biomed Mater Res B Appl Biomater 2006, 76(2):456-468.
30. Anseth KS,Newman SM, Bowman CN: Polymeric dental composites: properties and reaction behavior of multimethacrylate dental restorations. Adv Polym Sci 1995, 122:177-217.
31. Balgude AP, Yu X, Szymanski A, Bellamkonda RV: Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials 2001, 22(10):1077-1084.
32. Mauck RL, Soltz MA, Wang CC, Wong DD, Chao PH, et al.: Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng 2000, 122(3):252-260.
33. Jain A, Kim YT, Mckeon RJ, Bellamkonda RV: In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials 2006, 27(3):497-504.
34. Gupta D, Tator CH, Shoichet MS: Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 2006, 27(11):2370-2379.
35. Hamann MCJ, Tator CH, Shoichet MS: Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol 2005, 194(1):106-119.
36. Hamann MCJ, Tsai EC, Tator CH, Shoichet MS: Novel intrathecal delivery system for treatment of spinal cord injury. Exp Neurol 2003, 182(2):300-309.
37. Chung C, Mesa J, Miller GJ, Randolph MA, Gill TJ, et al.: Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. Tissue Eng 2006, 12(9):2665-2673.
38. Chung C, Mesa J, Randolph MA, Yaremchuk M, Burdick JA: Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks. J BiomedMater Res A 2006, 77A(3):518-525.
39. Peattie RA, Rieke ER, Hewett EM, Fisher RJ, Shu XZ, et al.: Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials 2006, 27(9):1868-1875.
40. Elisseeff J, Mcintosh W, Anseth K, Riley S, Ragan P, et al.: Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J BiomedMater Res 2000, 51(2):164-171.
41. Metters AT, Anseth KS, Bowman CN: Fundamental studies of a novel, biodegradable PEG-b-PLA hydrogel. Polymer 2000, 41(11):3993-4004.
42. Sawhney AS, Pathak CP, Hubbell JA: Bioerodible hydrogels based on photopolymerized poly(Ethylene Glycol)-Co-Poly(Alpha-Hydroxy Acid) diacrylate macromers. Macromolecules 1993, 26(4):581-587.
43. West JL, Hubbell JA: Photopolymerized hydrogel materials for drug-delivery applications. React Polym 1995, 25(2-3):139-147.
44. Lu SX, Anseth KS: Release behavior of high molecular weight solutes from poly(ethylene glycol)- based degradable networks. Macromolecules 2000, 33(7):2509-2515.
45. Mason MN, Metters AT, Bowman CN, Anseth KS: Predicting controlled-release behavior of degradable PLA-b-PEG-b-PLA hydrogels. Macromolecules 2001, 34(13):4630-4635.
46. Anseth KS, Metters AT, Bryant SJ, Martens PJ, Elisseeff JH, et al.: In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release 2002, 78(1-3):199-209.
47. Burdick JA, Mason MN, Hinman AD, Thorne K, Anseth KS: Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J Controlled Release 2002, 83(1):53-63.
48. Burdick JA, Ward M, Liang E, Young MJ, Langer R: Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 2006, 27(3):452-459.
49. Piantino J, Burdick JA, Goldberg D, Langer R, Benowitz LI: An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol 2006, 201(2):359-367.
50. Bellamkonda RV: Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy. Biomaterials 2006, 27(19):3515-3518.
51. Goda T, Ishihara K: Soft contact lens biomaterials from bioinspired phospholipid polymers. Expert Rev Med Devices 2006, 3(2):167-174.
52. Oral E, Peppas NA: Hydrophilicmolecularly imprinted poly(hydroxyethyl-methacrylate) polymers. J Biomed Mater Res A 2006, 78(1):205-210.
53. Piotrowicz A, Shoichet MS: Nerve guidance channels as drug delivery vehicles. Biomaterials 2006, 27(9):2018-2027.
54. Kapur TA, Shoichet MS: Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. J BiomedMaterRes A 2004, 68A(2):235-243.
55. Moore K,Macsween M, Shoichet M: Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. Tissue Eng 2006, 12(2):267-278.
56. Belkas JS, Munro CA, Shoichet MS, Midha R: Peripheral nerve regeneration through a synthetic hydrogel nerve tube. Restor Neurol Neurosci 2005, 23(1):19-29.
57. Tsai EC, Dalton PD, Shoichet MS, Tator CH: Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 2006, 27(3):519-533.
58. Bakshi A, Fisher O, Daggi T, Himes BT, Fischer I, et al.: Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury. J Neurosurg Spine 2004, 1(3):322-329.
59. Yu TT, Shoichet MS: Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials 2005, 26(13):1507-1514.
60. Bryant SJ, Cuy JL, Hauch KD, Ratner BD: Photopatterning of porous hydrogels for tissue engineering. Biomaterials 2007, 28(19):2978-2986.
61. Stachowiak AN, Bershteyn A, Tzatzalos E, Irvine DJ: Bioactive hydrogels with an ordered cellular structure combine interconnected macroporosity and robust mechanical properties. Adv Mater 2005, 17(4):399.
62. Stokols S, Tuszynski MH: The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury. Biomaterials 2004, 25(27):5839-5846.
63. Stokols S, Tuszynski MH: Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials 2006, 27(3):443-451.
64. Stokols S, Sakamoto J, Breckon C, Holt T, Weiss J, et al.: Templated agarose scaffolds support linear axonal regeneration. Tissue Eng 2006, 12(10):2777-2787.
65. Nomura H, Katayama Y, Shoichet MS, Tator CH: Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump. Neurosurgery 2006, 59(1):183-192.
66. Doh J, Irvine DJ: Photogenerated polyelectrolyte bilayers from an aqueous-processible photoresist for multicomponent protein patterning. J Am Chem Soc 2004, 126(30):9170-9171.
67. Katz JS, Doh J, Irvine DJ: Composition-tunable properties of amphiphilic comb copolymers containing protected methacrylic acid groups for multicomponent protein patterning. Langmuir 2006, 22(1):353-359.
68. Luo Y, Shoichet MS: Light-activated immobilization of biomolecules to agarose hydrogels for controlled cellular response. Biomacromolecules 2004, 5(6):2315-2323.
69. Luo Y, Shoichet MS: A photolabile hydrogel for guided three-dimensional cell growth and migration. Nat Mater 2004, 3(4):249-253.
70. Dodla MC, Bellamkonda RV: Anisotropic scaffolds facilitate enhanced neurite extension in vitro. J Biomed Mater Res A 2006, 78A(2):213-221.
71. Pittier R, Sauthier F, Hubbell JA, Hall H: Neurite extension and in vitro myelination within threedimensional modified fibrin matrices. J Neurobiol 2005, 63(1):1-14.
72. Wong C, Inman E, Spaethe R, Helgerson S: Fibrinbased biomaterials to deliver human growth factors. Thromb Haemost 2003, 89(3):573-582.
73. Lee AC, Yu VM, Lowe JB, Brenner MJ, Hunter DA, et al.: Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 2003, 184(1):295-303.
74. Sakiyama-Elbert SE, Hubbell JA: Controlled release of nerve growth factor from a heparin-containing fibrinbased cell ingrowth matrix. J Control Release 2000, 69(1):149-158.
75. Taylor SJ, Mcdonald JW, Sakiyama-Elbert SE: Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Controlled Release 2004, 98(2):281-294.
76. Taylor SJ, Rosenzweig ES, Mcdonald JW, Sakiyama-Elbert SE: Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release 2006, 113(3):226-235.
77. Willerth SM, Johnson PJ, Maxwell DJ, Parsons SR, Doukas ME, et al.: Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A 2007, 80A(1):13-23.
78. Goraltchouk A, Scanga V, Morshead CM, Shoichet MS: Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Controlled Release 2006, 110(2):400-407.
79. Mahoney MJ, Saltzman WM: Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat Biotechnol 2001, 19(10):934-939.
80. Ward MS, Khoobehi A, Lavik EB, Langer R, Young MJ: Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J Pharm Sci Technol 2007, 96(3):558-568.
81. Yu XJ, Bellamkonda RV: Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng 2003, 9(3):421-430.
82. Yang Y, De Laporte L, Rives CB, Jang JH, Lin WC, et al.: Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release 2005, 104(3):433-446.
83. Lavik EB, Klassen H, Warfvinge K, Langer R, Young MJ: Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials 2005, 26(16):3187-3196.
84. Levenberg S, Burdick JA, Kraehenbuehl T, Langer R: Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue Eng 2005, 11(3-4):506-512.
85. Chilkoti A, Dreher MR, Meyer DE, Raucher D: Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002, 54(5):613-630.
86. Das M, Sanson N, Fava D, Kumacheva E: Microgels loaded with gold nanorods: photothermally triggered volume transitions under physiological conditions. Langmuir 2007, 23(1):196-201.
87. Henry SM, El-Sayed MEH, Pirie CM, Hoffman AS, Stayton PS: pH-responsive poly(styrenealt- maleic anhydride) alkylamide copolymers for intracellular drug delivery. Biomacromolecules 2006, 7(8):2407-2414.
88. Yin X, Hoffman AS, Stayton PS: Poly(Nisopropylacrylamide- co-propylacrylic acid) copolymers that respond sharply to temperature and pH. Biomacromolecules 2006, 7(5):1381-1385.
89. Akino M, Odonnell M, Robitaille PML, Stokes BT: Phosphorus-31 magnetic resonance spectroscopy studies of pig spinal cord injury - Myelin changes, intracellular pH, and bioenergetics. Invest Radiol 1997, 32(7):382-388.
90. Mi RF, Chen WR, Hoke A: Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc Natl Acad Sci USA 2007, 104(11):4664-4669.